Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Dna Methylation As A Triage Tool For Cervical Cancer Screening - A Meeting Report.
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Dna Methylation As A Triage Tool For Cervical Cancer Screening - A Meeting Report.

Related Experiment Video

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

8.6K

DNA methylation as a triage tool for cervical cancer screening - A meeting report.

F Ricardo Burdier1, Dur-E-Nayab Waheed1, Belinda Nedjai2

  • 1Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Belgium.

Preventive Medicine Reports
|March 25, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

DNA methylation shows promise as a biomarker for human papillomavirus (HPV) infection, distinguishing between lesions that may regress and those that could progress to cancer. Further validation is needed for widespread implementation in cervical cancer screening.

Keywords:
Cervical cancer screeningHPV-related diseaseHuman papillomavirus infectionMethylation

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.5K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.6K

Related Experiment Videos

Methyl-binding DNA capture Sequencing for Patient Tissues
08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

8.6K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

5.5K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.6K

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • DNA methylation is emerging as a key biomarker for monitoring human papillomavirus (HPV) infection.
  • It holds potential for differentiating HPV-induced lesions with varying clinical outcomes, from regression to progression towards cancer.

Purpose of the Study:

  • To summarize expert discussions on DNA methylation's role in HPV infection and cervical cancer.
  • To explore DNA methylation validation in various sample types and populations, including women with HIV.
  • To assess the implementation of DNA methylation markers in cervical cancer screening programs.

Main Methods:

  • The report summarizes presentations and discussions from a technical meeting focused on DNA methylation.
  • Key areas included validation in clinician-collected and self-collected samples, discovery of new markers, and implementation strategies.
Molecular biomarker
Prognostic biomarker
Self-sampling
Triage
  • Discussions also covered the potential utility in women living with human immunodeficiency virus (HIV).

    • Main Results:

    • HPV-positive women with negative baseline methylation showed lower cervical cancer incidence than cytology-negative women.
    • DNA methylation is a promising triage strategy for cervical cancer screening.
    • Standardized data across diverse settings, sample types, study designs, and populations are required for robust validation.

    Conclusions:

    • International validation guidelines are crucial for the accurate validation and implementation of DNA methylation markers.
    • DNA methylation analysis offers a potential advancement in cervical cancer screening and management.